Pennington, Betty

Loading...
Profile Picture
Biography
After qualifying as a paramedic in 2008, I first started pursuing my interest in research by completing an MSc Professional Practice (Research & Development) alongside working as a paramedic in NWAS. I took up my first research paramedic secondment in 2012, working on the Head Injury Transportation Straight to Neurosurgery (HITS-NS) study, and have since supported other studies in a research paramedic role including: the Paramedic Acute Stroke Treatment Assessment (PASTA) trial; the Pre-hospital Evaluation of Sensitive Troponin (PRESTO) study; and the Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE). I am currently in post as an NIHR CRN Greater Manchester Research Paramedic supporting NIHR research, and this has included taking on the principal investigator role for the Impact of Restart a Heart Day 2019 in the UK study. I am particularly keen to support and encourage others in the ambulance service to get involved with research.
Institutional profile
The North West Ambulance Service NHS Trust is proud to be a research-active organisation, which develops and hosts research studies with a focus on pre-hospital healthcare, injuries and emergencies and other clinical specialities. The Trust also explores non-clinical research opportunities involving the organisation and the workforce.

Publication Search Results

Now showing 1 - 2 of 2
  • Publication
    Impact of COVID-19 on out-of-hospital cardiac arrest care processes
    (2023-02-02) Pennington, Betty; Bell, Steve; Wright, Adam; Hill, James E.
    Early bystander cardiopulmonary resuscitation, use of defibrillators (including automated external defibrillators) and timely treatment by emergency medical services are known to increase the chances of survival for a patient experiencing an out-of-hospital cardiac arrest (OHCA). However, the impact of the COVID-19 pandemic on this is unclear from examining previous literature. This commentary critically appraises a recent systematic review and meta-analysis, which assessed the effect of the COVID-19 pandemic on prehospital care for OHCA. Abstract published with permission.
  • Publication
    Administering naloxone: is the answer under our noses?
    (2009-06-01) Bisset, Elspeth
    The intranasal (IN) administration of naloxone to treat opioid overdoses offers many benefi ts over the current, often problematic intravenous and intramuscular routes. Such problems include using sharps around potentially aggressive patients; a high risk of transmitting blood-borne infections and diffi culty obtaining intravenous access in injecting drug users. A literature search was undertaken to examine the effectiveness of the IN route of naloxone administration in comparison to these other routes. Research suggests that the IN route is safe to introduce into practice and it is effective: the time taken from ambulance staff arriving at opioid overdose patients to them responding to IN naloxone appears to equal that of the intravenous route. Intranasal naloxone is not yet licensed for use in the UK and this needs to be reviewed. In the future this method of drug administration should result in considerable benefits and improved safety to both ambulance staff and patients, particularly for the treatment of opioid overdoses. Abstract published with permission